254 results on '"Fiorelli, Gemino"'
Search Results
2. A Baboon Model to Test Physiological and Adverse Effects of Human Red Cells Loaded with Inositol Hexaphosphate (IHP)
3. Determination of Purity of Commercially Available Inositol Hexaphosphate (Phytates) and Preparation of a Reference Material
4. Determination of Inositol Hexaphosphate (IHP) in Human IHP-Loaded Red Blood Cells by a Simple High Performance Liquid Chromatography Method
5. Behaviour of Glucose-6-Phosphate Dehydrogenase during Erythroid Maturation
6. Changes in erythropoiesis, iron metabolism and oxidative stress after half-marathon
7. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload
8. G6PD Ferrara I has the same two mutations as G6PD A(-) but a distinct biochemical phenotype
9. Exercise capacity in patients with β-thalassaemia intermedia
10. CYTOTOXIC T-LYMPHOCYTE ANTIGEN-4 A49G POLYMORPHISM IS ASSOCIATED WITH SUSCEPTIBILITY TO AND SEVERITY OF ALCOHOLIC LIVER DISEASE IN ITALIAN PATIENTS
11. Membrane-bound iron contributes to oxidative damage of β-thalassaemia intermedia erythrocytes
12. Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon
13. Haemochromatosis in patients with β-thalassaemia trait
14. Relationship between TNF-α and iron metabolism in differentiating human monocytic THP-1 cells
15. FUNCTIONAL RELEVANT SEQUENCES OF UROPORPHYRINOGEN DECARBOXYLASE ARE ANTIBODY TARGETS IN PORPHYRIA CUTANEA TARDA
16. THE INTERACTION BETWEEN GILBERT'S SYNDROME AND G6PD DEFICIENCY INFLUENCES BILIRUBIN LEVELS
17. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia
18. Molecular characterisation of the glucose-6-phosphate dehydrogenase (G6PD) Ferrara II variant
19. HIGH PREVALENCE OF CLINICALLY SILENT HCV INFECTION IN OLDER PEOPLE
20. Butyrate Trialsa
21. A Baboon Model to Test Physiological and Adverse Effects of Human Red Cells Loaded with Inositol Hexaphosphate (IHP)
22. Determination of Inositol Hexaphosphate (IHP) in Human IHP-Loaded Red Blood Cells by a Simple High Performance Liquid Chromatography Method
23. Tumor necrosis factor a promoter polymorphisms and insulinp resistance in nonalcoholic fatty liver disease
24. Hematologically Important Mutations: Acute Intermittent Porphyria
25. Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients
26. Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
27. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency
28. Prevalence and clinical significance of hepatitis G virus infection in adult beta-thalassaemia major patients
29. Hepatitis G virus infection in hemodialysis patients
30. Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C
31. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload
32. Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis
33. Tumor necrosis factor α promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis
34. Mutations in the HFE Gene and Their Interaction with Exogenous Risk Factors in Hepatocellular Carcinoma
35. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease
36. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
37. Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants
38. Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study
39. Autonomic control of heart period in duodenal ulcer patients: Insights from spectral analysis of heart rate variability
40. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?
41. Analysis of the genes for transferrin, transferrin receptor as well as H and L subunits of ferritin in idiopathic hemochromatosis
42. A fluorescein isothiocyanate (FITC) standard for quantification in immunofluorescence microscopy. Application to microfluorometry of human peripheral blood lymphocyte membrane IgM receptors
43. Characteristics of the Membrane Receptor for Human H-Ferritin
44. Prenatal Diagnosis and Carrier Detection of Hemophilia A
45. Non-Specific Iron in Patients with Beta-Thalassaemia Trait and Chronic Active Hepatitis
46. Clinical, biochemical and histological features of primary haemochromatosis: a report of 67 cases
47. Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C
48. MUTATION ANALYSIS OF HEPCIDIN AND FERROPORTIN GENES: POSSIBLE RELATIONSHIP WITH IRON OVERLOAD IN ITALIAN PROSPECTIVE BLOOD-DONORS
49. Exercise capacity in patients with beta-thalassaemia intermedia
50. Molecular Analysis of Alpha Hemoglobin Stabilizing Protein (AHSP) in Caucasian Patients with different Beta-Thalassemia Phenotypes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.